Debt-to-equity in % of Sonnet BioTherapeutics Holdings, Inc. from Q1 2012 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Debt-to-equity history and change rate from Q1 2012 to Q2 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 1,258%, a 598% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 1,258% +1,078% +598% 30 Jun 2025
Q1 2025 187% -16% -8% 31 Mar 2025
Q4 2024 135% -72% -35% 31 Dec 2024
Q3 2024 155% -416% -73% 30 Sep 2024
Q2 2024 180% -978% -84% 30 Jun 2024
Q1 2024 203% -55,171% -100% 31 Mar 2024
Q4 2023 206% -728% -78% 31 Dec 2023
Q3 2023 571% +459% +409% 30 Sep 2023
Q2 2023 1,158% +1,108% +2,184% 30 Jun 2023
Q1 2023 55,373% +55,325% +114,776% 31 Mar 2023
Q4 2022 934% +880% +1,646% 31 Dec 2022
Q3 2022 112% +10% +9.7% 30 Sep 2022
Q2 2022 51% -508% -91% 30 Jun 2022
Q1 2022 48% -620% -93% 31 Mar 2022
Q4 2021 54% +1,890% 31 Dec 2021
Q3 2021 102% +3,149% 30 Sep 2021
Q2 2021 558% +1,455% 30 Jun 2021
Q1 2021 668% +4,648% 31 Mar 2021
Q4 2020 -1,836% -3,584% -205% 31 Dec 2020
Q3 2020 -3,047% -3,677% -584% 30 Sep 2020
Q2 2020 -896% -1,613% -225% 30 Jun 2020
Q1 2020 -3,981% -4,484% -891% 31 Mar 2020
Q4 2019 1,748% +1,390% +389% 31 Dec 2019
Q3 2019 629% +327% +108% 30 Sep 2019
Q2 2019 717% +518% +262% 30 Jun 2019
Q1 2019 503% +324% +180% 31 Mar 2019
Q4 2018 357% +192% +116% 31 Dec 2018
Q3 2018 302% +140% +87% 30 Sep 2018
Q2 2018 198% 30 Jun 2018
Q1 2018 180% 31 Mar 2018
Q4 2017 165% 31 Dec 2017
Q3 2017 161% 30 Sep 2017
Q2 2014 78% +27% +53% 30 Jun 2014
Q1 2014 79% +46% +141% 31 Mar 2014
Q4 2013 76% +15% +24% 31 Dec 2013
Q3 2013 66% -34% -34% 30 Sep 2013
Q2 2013 51% -127% -71% 30 Jun 2013
Q1 2013 33% -792% -96% 31 Mar 2013
Q4 2012 62% 31 Dec 2012
Q3 2012 100% 30 Sep 2012
Q2 2012 178% 30 Jun 2012
Q1 2012 825% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.